Affordable human papillomavirus screening needed to eradicate cervical cancer for all
Authors:
Open Access
- 1 December 2019
- journal article
- editorial
- Published by Elsevier in The Lancet Global Health
- Vol. 7 (12) , e1605-e1606
Abstract
No abstract availableThis publication has 6 references indexed in Scilit:
- When and how often to screen for cervical cancer in three low- and middle-income countries: A cost-effectiveness analysisPapillomavirus Research, 2015
- Clinical Evaluation of the Cartridge-Based GeneXpert Human Papillomavirus Assay in Women Referred for ColposcopyJournal of Clinical Microbiology, 2014
- A Multicountry Evaluation of careHPV Testing, Visual Inspection With Acetic Acid, and Papanicolaou Testing for the Detection of Cervical CancerInternational Journal of Gynecological Cancer, 2014
- Cost-effectiveness of cervical cancer screening with primary human papillomavirus testing in NorwayBritish Journal of Cancer, 2012
- Human Papillomavirus Testing in the Prevention of Cervical CancerJNCI: Journal of the National Cancer Institute, 2011
- Cost-Effectiveness of Cervical-Cancer Screening in Developing CountriesNew England Journal of Medicine, 2006